nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Topotecan—peripheral nervous system neoplasm	0.107	0.138	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0739	0.0959	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0608	0.0789	CbGbCtD
Zafirlukast—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0528	0.0685	CbGbCtD
Zafirlukast—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0455	0.0591	CbGbCtD
Zafirlukast—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.044	0.057	CbGbCtD
Zafirlukast—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0424	0.0551	CbGbCtD
Zafirlukast—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0417	0.0541	CbGbCtD
Zafirlukast—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0385	0.05	CbGbCtD
Zafirlukast—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0368	0.0478	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0351	0.0456	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0297	0.0386	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0284	0.0369	CbGbCtD
Zafirlukast—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.023	0.0299	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0222	0.0288	CbGbCtD
Zafirlukast—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0214	0.0278	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0172	0.0223	CbGbCtD
Zafirlukast—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0158	0.0205	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00983	0.0128	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00966	0.0125	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00901	0.0117	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00614	0.00797	CbGbCtD
Zafirlukast—Tolvaptan—ABCB1—peripheral nervous system neoplasm	0.00186	0.768	CrCbGaD
Zafirlukast—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000671	0.0627	CbGpPWpGaD
Zafirlukast—Glyburide—ABCB1—peripheral nervous system neoplasm	0.00056	0.232	CrCbGaD
Zafirlukast—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000413	0.00191	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000411	0.0019	CcSEcCtD
Zafirlukast—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000411	0.0019	CcSEcCtD
Zafirlukast—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.0019	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000408	0.00188	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.00188	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000407	0.00188	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000405	0.00187	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.00186	CcSEcCtD
Zafirlukast—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000399	0.00184	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000399	0.00184	CcSEcCtD
Zafirlukast—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000397	0.00184	CcSEcCtD
Zafirlukast—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000397	0.00184	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000396	0.037	CbGpPWpGaD
Zafirlukast—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000396	0.00183	CcSEcCtD
Zafirlukast—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000396	0.00183	CcSEcCtD
Zafirlukast—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Zafirlukast—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000391	0.0365	CbGpPWpGaD
Zafirlukast—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000391	0.00181	CcSEcCtD
Zafirlukast—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000389	0.0018	CcSEcCtD
Zafirlukast—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000385	0.036	CbGpPWpGaD
Zafirlukast—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00178	CcSEcCtD
Zafirlukast—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00038	0.00176	CcSEcCtD
Zafirlukast—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00175	CcSEcCtD
Zafirlukast—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.00173	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00173	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000371	0.00172	CcSEcCtD
Zafirlukast—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00037	0.00171	CcSEcCtD
Zafirlukast—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00171	CcSEcCtD
Zafirlukast—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000367	0.0017	CcSEcCtD
Zafirlukast—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000367	0.0017	CcSEcCtD
Zafirlukast—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000366	0.00169	CcSEcCtD
Zafirlukast—Oedema—Vincristine—peripheral nervous system neoplasm	0.000364	0.00168	CcSEcCtD
Zafirlukast—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000362	0.00168	CcSEcCtD
Zafirlukast—Infection—Vincristine—peripheral nervous system neoplasm	0.000362	0.00167	CcSEcCtD
Zafirlukast—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00036	0.00167	CcSEcCtD
Zafirlukast—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00165	CcSEcCtD
Zafirlukast—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00165	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000356	0.00165	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00165	CcSEcCtD
Zafirlukast—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000356	0.00164	CcSEcCtD
Zafirlukast—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000355	0.00164	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000354	0.0331	CbGpPWpGaD
Zafirlukast—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Zafirlukast—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Zafirlukast—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000352	0.00163	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000351	0.00162	CcSEcCtD
Zafirlukast—Back pain—Etoposide—peripheral nervous system neoplasm	0.000349	0.00162	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000348	0.00161	CcSEcCtD
Zafirlukast—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000348	0.00161	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.0016	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.00159	CcSEcCtD
Zafirlukast—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000344	0.00159	CcSEcCtD
Zafirlukast—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00158	CcSEcCtD
Zafirlukast—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00158	CcSEcCtD
Zafirlukast—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00158	CcSEcCtD
Zafirlukast—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000337	0.00156	CcSEcCtD
Zafirlukast—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000336	0.00155	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.00155	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000335	0.00155	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000333	0.00154	CcSEcCtD
Zafirlukast—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00154	CcSEcCtD
Zafirlukast—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000332	0.00154	CcSEcCtD
Zafirlukast—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00153	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000332	0.00153	CcSEcCtD
Zafirlukast—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00152	CcSEcCtD
Zafirlukast—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00152	CcSEcCtD
Zafirlukast—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000329	0.00152	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00151	CcSEcCtD
Zafirlukast—Malaise—Etoposide—peripheral nervous system neoplasm	0.000326	0.00151	CcSEcCtD
Zafirlukast—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00151	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.0015	CcSEcCtD
Zafirlukast—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00149	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Zafirlukast—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Zafirlukast—Infection—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00148	CcSEcCtD
Zafirlukast—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000319	0.00148	CcSEcCtD
Zafirlukast—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Zafirlukast—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Zafirlukast—Rash—Topotecan—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Zafirlukast—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000316	0.00146	CcSEcCtD
Zafirlukast—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000315	0.00146	CcSEcCtD
Zafirlukast—Headache—Topotecan—peripheral nervous system neoplasm	0.000315	0.00145	CcSEcCtD
Zafirlukast—Rash—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Zafirlukast—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000313	0.00145	CcSEcCtD
Zafirlukast—Headache—Tretinoin—peripheral nervous system neoplasm	0.000312	0.00144	CcSEcCtD
Zafirlukast—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000312	0.00144	CcSEcCtD
Zafirlukast—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00144	CcSEcCtD
Zafirlukast—Pain—Vincristine—peripheral nervous system neoplasm	0.000311	0.00144	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00144	CcSEcCtD
Zafirlukast—Rash—Melphalan—peripheral nervous system neoplasm	0.00031	0.00143	CcSEcCtD
Zafirlukast—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00031	0.00143	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00143	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000304	0.0014	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0003	0.00139	CcSEcCtD
Zafirlukast—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00139	CcSEcCtD
Zafirlukast—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00138	CcSEcCtD
Zafirlukast—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00138	CcSEcCtD
Zafirlukast—Nausea—Topotecan—peripheral nervous system neoplasm	0.000298	0.00138	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000298	0.00138	CcSEcCtD
Zafirlukast—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000296	0.00137	CcSEcCtD
Zafirlukast—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.00137	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000293	0.00136	CcSEcCtD
Zafirlukast—Infection—Etoposide—peripheral nervous system neoplasm	0.000293	0.00135	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000292	0.00135	CcSEcCtD
Zafirlukast—Nausea—Melphalan—peripheral nervous system neoplasm	0.000292	0.00135	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000289	0.00133	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00133	CcSEcCtD
Zafirlukast—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000288	0.00133	CcSEcCtD
Zafirlukast—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000288	0.00133	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.00133	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000279	0.00129	CcSEcCtD
Zafirlukast—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.00129	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00128	CcSEcCtD
Zafirlukast—Pain—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00127	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000275	0.0257	CbGpPWpGaD
Zafirlukast—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00126	CcSEcCtD
Zafirlukast—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00125	CcSEcCtD
Zafirlukast—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000268	0.00124	CcSEcCtD
Zafirlukast—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00124	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00123	CcSEcCtD
Zafirlukast—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00123	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000262	0.0245	CbGpPWpGaD
Zafirlukast—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000261	0.00121	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.0012	CcSEcCtD
Zafirlukast—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00119	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000257	0.00119	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000255	0.00118	CcSEcCtD
Zafirlukast—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00118	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000254	0.00118	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00117	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00117	CcSEcCtD
Zafirlukast—Pain—Etoposide—peripheral nervous system neoplasm	0.000252	0.00117	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00116	CcSEcCtD
Zafirlukast—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00115	CcSEcCtD
Zafirlukast—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000249	0.00115	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000246	0.0229	CbGpPWpGaD
Zafirlukast—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00112	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000243	0.00112	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.00112	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00112	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000241	0.00111	CcSEcCtD
Zafirlukast—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000241	0.00111	CcSEcCtD
Zafirlukast—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00111	CcSEcCtD
Zafirlukast—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.0011	CcSEcCtD
Zafirlukast—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.0011	CcSEcCtD
Zafirlukast—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000237	0.0011	CcSEcCtD
Zafirlukast—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00109	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00109	CcSEcCtD
Zafirlukast—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000235	0.0219	CbGpPWpGaD
Zafirlukast—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000234	0.00108	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00108	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00108	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00107	CcSEcCtD
Zafirlukast—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000231	0.00107	CcSEcCtD
Zafirlukast—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00107	CcSEcCtD
Zafirlukast—Rash—Vincristine—peripheral nervous system neoplasm	0.000229	0.00106	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000229	0.00106	CcSEcCtD
Zafirlukast—Headache—Vincristine—peripheral nervous system neoplasm	0.000228	0.00105	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00104	CcSEcCtD
Zafirlukast—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00104	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00103	CcSEcCtD
Zafirlukast—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00102	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000217	0.001	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.001	CcSEcCtD
Zafirlukast—Nausea—Vincristine—peripheral nervous system neoplasm	0.000216	0.000999	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000995	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000995	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00099	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000212	0.000978	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000209	0.000964	CcSEcCtD
Zafirlukast—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000946	CcSEcCtD
Zafirlukast—Rash—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000938	CcSEcCtD
Zafirlukast—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000937	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000202	0.000933	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.0002	0.0187	CbGpPWpGaD
Zafirlukast—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000905	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000195	0.000901	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000192	0.0179	CbGpPWpGaD
Zafirlukast—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000884	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000869	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000187	0.000867	CcSEcCtD
Zafirlukast—Rash—Etoposide—peripheral nervous system neoplasm	0.000186	0.000859	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000186	0.000859	CcSEcCtD
Zafirlukast—Headache—Etoposide—peripheral nervous system neoplasm	0.000185	0.000854	CcSEcCtD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000183	0.0171	CbGpPWpGaD
Zafirlukast—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000844	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000182	0.017	CbGpPWpGaD
Zafirlukast—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000838	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000178	0.0166	CbGpPWpGaD
Zafirlukast—Nausea—Etoposide—peripheral nervous system neoplasm	0.000175	0.00081	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000804	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000797	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000797	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000787	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000781	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000764	CcSEcCtD
Zafirlukast—Infection—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000759	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000748	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000737	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000737	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000159	0.0149	CbGpPWpGaD
Zafirlukast—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000729	CcSEcCtD
Zafirlukast—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000154	0.0143	CbGpPWpGaD
Zafirlukast—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000707	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000702	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000696	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000692	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000691	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000672	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00066	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000659	CcSEcCtD
Zafirlukast—Pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000653	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000644	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000138	0.0129	CbGpPWpGaD
Zafirlukast—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000639	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00063	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000625	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000622	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000133	0.0124	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00061	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000609	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000607	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000604	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000604	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000604	CcSEcCtD
Zafirlukast—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00013	0.0122	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000583	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000578	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000123	0.0115	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000563	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000562	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000559	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000559	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000548	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000118	0.011	CbGpPWpGaD
Zafirlukast—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000541	CcSEcCtD
Zafirlukast—CYSLTR2—Endothelins—HRAS—peripheral nervous system neoplasm	0.000114	0.0106	CbGpPWpGaD
Zafirlukast—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000523	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000113	0.0106	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000521	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00011	0.0103	CbGpPWpGaD
Zafirlukast—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000507	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000505	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.0005	CcSEcCtD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000108	0.0101	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000108	0.0101	CbGpPWpGaD
Zafirlukast—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000486	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000484	CcSEcCtD
Zafirlukast—Rash—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000482	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000481	CcSEcCtD
Zafirlukast—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000104	0.00972	CbGpPWpGaD
Zafirlukast—Headache—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000479	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000103	0.00958	CbGpPWpGaD
Zafirlukast—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000467	CcSEcCtD
Zafirlukast—CYSLTR2—Endothelins—AKT1—peripheral nervous system neoplasm	0.0001	0.00937	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.83e-05	0.00919	CbGpPWpGaD
Zafirlukast—Nausea—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000454	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000449	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	9.67e-05	0.00904	CbGpPWpGaD
Zafirlukast—Rash—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000446	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.63e-05	0.000445	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.000443	CcSEcCtD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	9.25e-05	0.00864	CbGpPWpGaD
Zafirlukast—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.00042	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.98e-05	0.00839	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.56e-05	0.008	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	8.52e-05	0.00796	CbGpPWpGaD
Zafirlukast—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.42e-05	0.00787	CbGpPWpGaD
Zafirlukast—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	8.4e-05	0.00785	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	8.17e-05	0.00764	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—HRAS—peripheral nervous system neoplasm	7.87e-05	0.00736	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.85e-05	0.00734	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	7.83e-05	0.00731	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.77e-05	0.00726	CbGpPWpGaD
Zafirlukast—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	7.68e-05	0.00718	CbGpPWpGaD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.31e-05	0.00684	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.17e-05	0.0067	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.11e-05	0.00664	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—AKT1—peripheral nervous system neoplasm	6.95e-05	0.0065	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	6.81e-05	0.00637	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	6.71e-05	0.00627	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	6.25e-05	0.00584	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.22e-05	0.00581	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.06e-05	0.00566	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	5.93e-05	0.00554	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.82e-05	0.00544	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.81e-05	0.00543	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.44e-05	0.00508	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.39e-05	0.00503	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.24e-05	0.0049	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.07e-05	0.00474	CbGpPWpGaD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.06e-05	0.00473	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	4.97e-05	0.00464	CbGpPWpGaD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.83e-05	0.00452	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.82e-05	0.00451	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.61e-05	0.0043	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.59e-05	0.00429	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.44e-05	0.00415	CbGpPWpGaD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.29e-05	0.00401	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.26e-05	0.00398	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.24e-05	0.00396	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.2e-05	0.00392	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	4.03e-05	0.00377	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.03e-05	0.00376	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.02e-05	0.00376	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.6e-05	0.00336	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.52e-05	0.00329	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.46e-05	0.00323	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.45e-05	0.00323	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.38e-05	0.00316	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.19e-05	0.00298	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.18e-05	0.00297	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.18e-05	0.00297	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.07e-05	0.00287	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.02e-05	0.00282	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.95e-05	0.00276	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.94e-05	0.00274	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.8e-05	0.00262	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.79e-05	0.00261	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.75e-05	0.00257	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.72e-05	0.00254	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.59e-05	0.00242	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.58e-05	0.00241	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.43e-05	0.00227	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.38e-05	0.00222	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.35e-05	0.0022	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.34e-05	0.00219	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.33e-05	0.00218	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.23e-05	0.00209	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.21e-05	0.00206	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.09e-05	0.00195	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.99e-05	0.00186	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.95e-05	0.00182	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.94e-05	0.00181	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.94e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.89e-05	0.00176	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.83e-05	0.00171	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.83e-05	0.00171	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.82e-05	0.0017	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.8e-05	0.00168	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.00164	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.74e-05	0.00163	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	1.69e-05	0.00158	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.68e-05	0.00157	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.68e-05	0.00157	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.65e-05	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.65e-05	0.00154	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.62e-05	0.00151	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	1.62e-05	0.00151	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	1.56e-05	0.00146	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.55e-05	0.00145	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.53e-05	0.00143	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.51e-05	0.00141	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.47e-05	0.00138	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.00135	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.35e-05	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.26e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.25e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.24e-05	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.23e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.23e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.21e-05	0.00113	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.2e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.19e-05	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.17e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.16e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.12e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.09e-05	0.00102	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	0.00102	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.06e-05	0.000994	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.05e-05	0.00098	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.000976	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.02e-05	0.000955	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000953	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.01e-05	0.00094	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.94e-06	0.000929	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	9.73e-06	0.000909	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	9.33e-06	0.000872	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.26e-06	0.000866	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.06e-06	0.000847	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	8.99e-06	0.00084	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	8.98e-06	0.000839	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	8.95e-06	0.000836	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	8.87e-06	0.000829	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.71e-06	0.000814	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	8.64e-06	0.000807	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	8.58e-06	0.000802	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.58e-06	0.000801	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.54e-06	0.000798	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	8.5e-06	0.000795	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	8.45e-06	0.00079	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.3e-06	0.000776	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	8.26e-06	0.000772	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.24e-06	0.00077	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.22e-06	0.000768	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	8.19e-06	0.000765	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	8.12e-06	0.000759	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.09e-06	0.000756	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	7.64e-06	0.000714	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.61e-06	0.000711	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	7.58e-06	0.000708	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.54e-06	0.000704	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.27e-06	0.00068	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	7.27e-06	0.000679	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	6.99e-06	0.000654	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	6.9e-06	0.000645	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.89e-06	0.000644	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.77e-06	0.000633	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	6.63e-06	0.00062	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	6.6e-06	0.000617	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.5e-06	0.000608	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	6.45e-06	0.000603	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.42e-06	0.0006	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.42e-06	0.0006	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.16e-06	0.000575	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	6.07e-06	0.000567	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	5.89e-06	0.000551	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.85e-06	0.000547	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.61e-06	0.000524	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	5.58e-06	0.000521	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	5.42e-06	0.000507	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.4e-06	0.000504	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	5.37e-06	0.000502	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.32e-06	0.000497	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.27e-06	0.000493	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	5.25e-06	0.00049	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.04e-06	0.000471	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	4.98e-06	0.000465	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	4.95e-06	0.000463	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.86e-06	0.000454	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.75e-06	0.000444	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	4.68e-06	0.000438	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.59e-06	0.000429	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	4.58e-06	0.000428	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	4.54e-06	0.000424	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.45e-06	0.000416	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.37e-06	0.000408	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.33e-06	0.000405	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	4.31e-06	0.000402	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.28e-06	0.0004	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.27e-06	0.000399	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.2e-06	0.000393	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.88e-06	0.000363	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	3.82e-06	0.000357	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	3.75e-06	0.00035	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.7e-06	0.000346	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.65e-06	0.000341	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.54e-06	0.000331	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.52e-06	0.000329	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	3.48e-06	0.000326	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-06	0.000322	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.42e-06	0.00032	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.99e-06	0.00028	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.98e-06	0.000278	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.92e-06	0.000273	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.86e-06	0.000267	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.82e-06	0.000263	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.3e-06	0.000215	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.26e-06	0.000211	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.86e-06	0.000174	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	1.79e-06	0.000167	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.34e-06	0.000125	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-06	0.000108	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.03e-06	9.64e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	9.49e-07	8.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	9.41e-07	8.79e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.04e-07	7.51e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.2e-07	5.8e-05	CbGpPWpGaD
